links

src/contents/judging.tsx

 import { BlockQuoteB } from "../components/Quotes";
 import { Section } from "../components/sections";
+import { useNavigation } from "../utils";
 import { useTabNavigation } from "../utils/TabNavigation";
 
 export function Judging() {
   useTabNavigation();
+  const {goToPagesAndOpenTab} = useNavigation(); 
     return (
       <>
         <Section title="Overview" id="Overview">
@@ -60,7 +62,7 @@ export function Judging() {
         <Section title="Best Integrated Human Practice" id="Best Integrated Human Practice">
           <p>Our team’s project at Bielefeld-CeBiTec integrates Human Practices into every aspect of our work, ensuring that our synthetic biology innovation aligns with societal needs, ethical considerations, and environmental sustainability. By proactively engaging with a broad range of stakeholders, including scientists, regulatory bodies, and community groups, we shaped our project to have meaningful and responsible impacts. Our commitment to understanding the broader implications of our work positions us as a strong candidate for the <b>Best Integrated Human Practices Award</b>. </p>
           <h4>Integration of Human Practices </h4>
-          <p>We actively engaged with a diverse array of stakeholders throughout our project, from CF patients like Max Beckmann[Link] to clinicians such as Prof. Dr. Olariu [Link], physiotherapists like Katrin Westhoff [Link], and industry experts including Dr. Benjamin Winkeljann [Link] and Dr. Katharina Kolonko [Link]. Each of these collaborations directly informed and shaped our therapeutic solution. Max Beckmann’s firsthand experience provided us with invaluable insights into the daily challenges of living with CF, helping us align our gene therapy with patient needs. Additionally, clinicians and physiotherapists guided us toward a treatment strategy that is practical, accessible, and effective for different patient demographics. </p>
+          <p>We actively engaged with a diverse array of stakeholders throughout our project, from CF patients like <a onClick={() => goToPagesAndOpenTab('maxfirst', '/human-practices')}>Max Beckmann</a>  to clinicians such as <a onClick={() => goToPagesAndOpenTab('olariu', '/human-practices')}>Dr. Olariu</a> , physiotherapists like <a onClick={() => goToPagesAndOpenTab('westhoffinv', '/human-practices')}>Katrin Westhoff</a>, and industry experts including <a onClick={() => goToPagesAndOpenTab('rnhale', '/human-practices')}>Dr. Benjamin Winkeljann</a> and <a onClick={() => goToPagesAndOpenTab('kolonkofirst', '/human-practices')}>Dr. Katharina Kolonko</a>. Each of these collaborations directly informed and shaped our therapeutic solution. Max Beckmann’s firsthand experience provided us with invaluable insights into the daily challenges of living with CF, helping us align our gene therapy with patient needs. Additionally, clinicians and physiotherapists guided us toward a treatment strategy that is practical, accessible, and effective for different patient demographics. </p>
           <h4>Inspiration to Others </h4>
           <p>Our project serves as a model for how synthetic biology can be leveraged to meet real-world needs while maintaining a patient-centered focus. By integrating feedback from patients and medical professionals, we demonstrate that cutting-edge science can coexist with empathy and responsibility. Our focus on inclusivity, scalability, and addressing global disparities in CF treatment sets a precedent for future iGEM teams looking to make a meaningful impact on health challenges. </p>
           <h4>Documentation for Future Teams </h4>